Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1

Yuki Ikematsu, Yasuto Yoneshima, Kayo Ijichi, Kentaro Tanaka, Taishi Harada, Yoshinao Oda, Yoichi Nakanishi, Isamu Okamoto

Research output: Contribution to journalLetter

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)230-231
Number of pages2
JournalLung Cancer
Volume112
DOIs
Publication statusPublished - Oct 2017

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this